Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Supplemental material
  • Footnotes
  • References
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research LetterGastroenterologyImmunology Open Access | 10.1172/JCI193413

Revealing hyperactivated IFN-γ pathways in perianal fistulizing Crohn’s disease using single-cell and spatial multi-omics

Siyan Cao,1 Khai M. Nguyen,2 Kaiming Ma,1 Tingyi Tan,1 Xin Yao,1 Ta-Chiang Liu,2 Malek Ayoub,1 Jalpa Devi,1 Sami Samaan,1 Yizhou Liu,2 Radhika Smith,3 Matthew L. Silviera,3 Steven R. Hunt,3 Paul E. Wise,3 Matthew G. Mutch,3 Sean C. Glasgow,3 William C. Chapman Jr.,3 Michelle L. Cowan,3 Matthew A. Ciorba,1 Marco Colonna,2 Parakkal Deepak,1 and SPARC IBD Investigators4

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Cao, S. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Nguyen, K. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Ma, K. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Tan, T. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Yao, X. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Liu, T. in: PubMed | Google Scholar |

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Ayoub, M. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Devi, J. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Samaan, S. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Liu, Y. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Smith, R. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Silviera, M. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Hunt, S. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Wise, P. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Mutch, M. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Glasgow, S. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Chapman, W. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Cowan, M. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Ciorba, M. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Colonna, M. in: PubMed | Google Scholar |

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Find articles by Deepak, P. in: PubMed | Google Scholar

1Division of Gastroenterology,

2Department of Pathology and Immunology, and

3Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

4The SPARC IBD Investigators are detailed in Supplemental Acknowledgments.

Address correspondence to: Siyan Cao, Marco Colonna, or Parakkal Deepak, Washington University, 660 S. Euclid Avenue, St. Louis, Missouri, 63110, USA. Phone: 314.526.6486; Email: caos@wustl.edu (SC). Phone: 314.362.0367; Email: mcolonna@wustl.edu (MC). Phone 314.273.1947; Email: deepak.parakkal@wustl.edu (PD).

Authorship note: SC and KMN are co–first authors.

Authorship note: SC and KMN are co–first authors.

Published July 3, 2025 - More info

Published in Volume 135, Issue 17 on September 2, 2025
J Clin Invest. 2025;135(17):e193413. https://doi.org/10.1172/JCI193413.
© 2025 Cao et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published July 3, 2025 - Version history
View PDF

To the Editor: Perianal fistulizing Crohn’s disease (PCD) occurs in up to 40% of patients with Crohn’s disease (CD), who are affected by substantial treatment resistance and high morbidity. The etiology of PCD remains poorly understood, hindering the development of preclinical models and effective therapies (1). Here, we utilized a multi-omics approach, including single-cell RNA sequencing (scRNA-Seq), cytometry by TOF (CyTOF), and spatial transcriptomics (ST) to characterize PCD, CD without perianal disease (NPCD), and idiopathic/cryptoglandular perianal fistula (IPF).

Fistula tract biopsies of 9 individuals with PCD and 6 with IPF (Supplemental Table 1; supplemental material available online with this article; https://doi.org/10.1172/JCI193413DS1) were analyzed using scRNA-Seq, which generated 56,560 high-quality cells (Figure 1A and Supplemental Figure 1A). Single-cell pathway analysis (SCPA) identified IFN-γ and TNF-α signaling as top activated pathways in PCD versus IPF (Figure 1B). Hyperactivated IFN-γ–responsive genes, including JAKs and STAT1, were present in major cell populations from PCD fistulas (Figure 1C and Supplemental Figure 1B). The transcriptomic data were validated by IHC, which showed increased IFN-γ and phosphorylated STAT1 in PCD (Figure 1D). By reanalyzing published scRNA-Seq datasets of rectum (2) (active PCD vs. inactive/healed PCD; n = 6/group) and colon and terminal ileum (3) (PCD vs. NPCD; n = 8 for PCD, n = 39 for NPCD), we showed upregulated IFN-γ and TNF-α pathways in all the 3 locations in PCD intestine compared with NPCD (Figure 1E). Reclustering of the rectal cells (2) uncovered similar induction of IFN-γ–responsive genes in multiple epithelial and immune cells from individuals with PCD and from individuals with healed PCD (Supplemental Figure 1C). Thus, PCD is characterized by heightened IFN-γ response in both fistula tracts and intestinal mucosa. Analysis of rectal epithelial cells (2) identified enriched clusters 9 and 12 with elevated IFN-γ, TNF-α, and EMT pathways in PCD compared with NPCD. IFN-γ and TNF-α responses were significantly correlated with EMT scores (Figure 1F). Compared with IPF, PCD fistulas exhibited increased extracellular matrix organization by stromal cells and cell adhesions by endothelial cells (Supplemental Figure 1D).

Hyperactivated IFN-γ signaling is a distinguishing feature of PCD in both fFigure 1

Hyperactivated IFN-γ signaling is a distinguishing feature of PCD in both fistula tracts and intestinal mucosa. (A) UMAP of major cell compartments in perianal fistulas. (B) Top upregulated pathways in PCD versus IPF fistulas by SCPA. (C) Altered gene expression in monocytes, macrophages, and dendritic cells in PCD versus IPF fistulas. (D) Representative IHC images and quantification in fistula tracts. Scale bar: 50 μm. **P < 0.01. (E) Top upregulated pathways in rectum (PCD vs. PCD healed) and colon/terminal ileum (PCD vs. NPCD) by SCPA. (F) UMAP of rectal epithelial cells; single-cell module scores; and correlation between TNF or IFNG response and EMT scores. (G) IFN-γ senders in PCD and IPF. (H) IFN-γ downstream genes in bulk RNA-Seq of CD intestinal samples. P values generated by Dunn’s post hoc test: STAT1, 0.019 (active vs. no PCD); IRF1, 0.00024 (active vs. no PCD) and 0.012 (inactive vs. no PCD); IRF8, 0.014 (active vs. no PCD).

Unbiased ligand-receptor analysis revealed PCD-enriched pairs (Supplemental Figure 2A) known to drive inflammation and EMT. Moreover, IFN-γ senders Th17 cells and Tregs were significantly enriched in PCD (Figure 1G). IFN-γ–producing Th17 cells represent a pathogenic antigen-induced state (4) (pathogenic Th17 [pTh17]), which may underlie the activated IFN-γ response. PCD myeloid cells overexpressed NLRP3, AREG, and IFN-γ–induced CXCL9/10 (Supplemental Figure 2B). Signaling by bacterial molecule LPS was upregulated in NLRP3+AREG+ cells (or LPS myeloid cells) and the entire myeloid compartment in PCD (Supplemental Figure 2C). Ligand-receptor analysis further revealed multiple myeloid-derived chemokines/cytokines that activate Th17 cells (Supplemental Figure 2D). IFN-γ–producing cells may also be upregulated by higher IL15 in PCD (Supplemental Figure 2E). Other elevated pathways in PCD myeloid cells include NOD2/RIPK2 and TL1A/DR3 (Supplemental Figure 2, G–I). Additionally, our CyTOF data revealed features of IFN-γ signaling and established LPS myeloid cells as a hallmark of PCD microenvironment across fistula tracts, fistula opening, and rectum (Supplemental Figure 2, J–L).

Anti-TNFs currently have the best evidence for PCD treatment, with unclear mechanisms (1). We subdivided our scRNA-Seq PCD cohort into anti-TNF–treated or anti-TNF–naive groups based on treatment at sampling (n = 4/group; all patients on anti-TNFs later responded to therapy). Weighted gene coexpression network analysis identified 2 gene modules significantly correlated with anti-TNFs: the “lightpink1” module suppressed by anti-TNFs associated with immune cell activation and IFN response, while the “royalblue2” module induced by anti-TNFs supported cell proliferation and wound healing (Supplemental Figure 2, M–O).

ST of IPF and PCD fistula tracts (n = 3/group) generated 6 spatially correlated clusters (C0–5; Supplemental Figure 3A). Epithelial cells lining the fistula tract in C1 primarily mapped to IFNGR+TNFR+, IFNG/TNF-responsive colonocytes (Supplemental Figure 3B), further supporting the roles of IFN-γ and TNF-α signaling in fistulization. LPS myeloid cells were ubiquitously present at tract-adjacent spots, suggesting their interactions with microbial elements in the fistula tract (Supplemental Figure 3C), while pTh17 closely colocalized with LPS myeloid cells (Supplemental Figure 3D). Notably, these cells were present in all PCD samples but were scarce in IPF (Supplemental Figure 3E).

Finally, we validated our single-cell findings using intestinal bulk RNA-Seq data of intestinal samples from patients with active PCD (n = 12), inactive PCD (n = 23), and NPCD (n = 84) in an independent SPARC-IBD cohort. The analysis demonstrated hyperactivation of IFN-γ response (e.g., STAT1, IRF1; Figure 1H), EMT/tissue remodeling, inflammation, and endoplasmic reticulum stress in PCD tissues (Supplemental Figure 3F). Current PCD treatments (e.g., anti-TNFs and upadacitinib) are mainly approved through registrational trials in luminal CD; they have moderate efficacy and cannot heal the fistulas in most cases (1, 5). The therapeutic potential of IFN-γ antagonists warrants investigation using physiologically relevant PCD models.

For detailed methods, information regarding sex as a biological variable, statistics, study approval, author contributions, data availability, and acknowledgments, see the supplemental materials.

Supplemental material

View Supplemental data

View Supplemental table 1

View Supporting data values

Footnotes

Conflict of interest: The conflict-of-interest statement is available in the Supplemental Material.

Authorship note: SC and KMN are co–first authors.

Copyright: © 2025, Cao et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.

Reference information: J Clin Invest. 2025;135(17):e193413. https://doi.org/10.1172/JCI193413.

References
  1. Cao S, et al. Pathogenesis of perianal fistulising Crohn’s disease: current knowledge, gaps in understanding, and future research directions. J Crohns Colitis. 2023;17(6):1010–1022.
    View this article via: CrossRef PubMed Google Scholar
  2. Washburn S, et al. Persistent inflammation of the rectum in perianal fistulizing Crohn’s disease is associated with goblet cell function. Gastro Hep Adv. 2024;3(1):131–133.
    View this article via: CrossRef PubMed Google Scholar
  3. Kong L, et al. The landscape of immune dysregulation in Crohn’s disease revealed through single-cell transcriptomic profiling in the ileum and colon. Immunity. 2023;56(2):444–458.
    View this article via: CrossRef PubMed Google Scholar
  4. Zielinski CE, et al. Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature. 2012;484(7395):514–518.
    View this article via: CrossRef PubMed Google Scholar
  5. Colombel JF, et al. Efficacy and safety of upadacitinib for perianal fistulizing Crohn’s disease: a post hoc analysis of 3 phase 3 trials. Clin Gastroenterol Hepatol. 2025;23(6):1019–1029.
    View this article via: CrossRef PubMed Google Scholar
Version history
  • Version 1 (July 3, 2025): In-Press Preview
  • Version 2 (September 2, 2025): Electronic publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Supplemental material
  • Footnotes
  • References
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts